PRKAA1 and T-cell acute lymphoblastic leukemia: In fact, miR-19b negatively regulates PRKAA1 and BIM in T-cell acute lymphoblastic leukemia, in addition to PPP2R5E, resulting in an overall PI3K signaling pathway activation [31].